genXone S.A. (WSE:GX1)
Poland
· Delayed Price · Currency is PLN 5.84
-0.06 (-1.02%)
Last updated: May 12, 2025
genXone Market Cap
genXone has a market cap or net worth of 19.30 million as of May 13, 2025. Its market cap has decreased by -14.16% in one year.
Market Cap
19.30M
Enterprise Value
13.85M
Revenue
1.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.84
Market Cap Chart
Since September 4, 2020, genXone's market cap has decreased from 141.69M to 19.30M, a decrease of -86.38%. That is a compound annual growth rate of -34.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 19.30M | -5.81% |
| Dec 30, 2024 | 20.49M | 15.53% |
| Dec 29, 2023 | 17.74M | -47.33% |
| Dec 30, 2022 | 33.67M | -51.33% |
| Dec 30, 2021 | 69.20M | 0.10% |
| Dec 30, 2020 | 69.13M | -51.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.24B |
| Synektik Spólka Akcyjna | 1.96B |
| Voxel | 1.72B |
| Celon Pharma | 1.29B |
| Ryvu Therapeutics | 793.02M |
| Selvita | 697.51M |
| Bioceltix | 585.03M |
| Centrum Medyczne ENEL-MED | 565.61M |